Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report

Hyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, Costas D. Lallas, Elai Davicioni, Jianqing Lin, Ruth Birbe, Nicholas Erho, Jonathan Lehrer, Hussam Al Deen Ashab, Mandeep Takhar, Anders Olson, Lucia L.C. Lam, W. Kevin Kelly, Karen E. Knudsen, Chellappagounder Thangavel, Roland Seiler, Felix Y. Feng, Edward M. Schaeffer, Edouard J. TrabulsiLeonard G. Gomella, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Management of men with prostate cancer is fraught with uncertainty as physicians and patients balance efficacy with potential toxicity and diminished quality of life. Utilization of genomics as a prognostic biomarker has improved the informed decision-making process by enabling more rationale treatment choices. Recently investigations have begun to determine whether genomic information from tumor transcriptome data can be used to impact clinical decision-making beyond prognosis. Here we discuss the potential of genomics to alter management of a patient who presented with high-risk prostate adenocarcinoma. We suggest that this information help selecting patients for advanced imaging, chemotherapies, or clinical trial.

Original languageEnglish (US)
Pages (from-to)51-54
Number of pages4
JournalUrology Case Reports
StatePublished - Nov 1 2016


  • Genomics
  • Neuroendocrine
  • Prostate

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report'. Together they form a unique fingerprint.

Cite this